Cargando…

At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction

BACKGROUND: In experimental models, Type 1 diabetes T1D can be prevented by adoptive transfer of CD4+CD25+ FoxP3+ suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Glisic-Milosavljevic, Sanja, Waukau, Jill, Jailwala, Parthav, Jana, Srikanta, Khoo, Huoy-Jii, Albertz, Hope, Woodliff, Jeffrey, Koppen, Marilyn, Alemzadeh, Ramin, Hagopian, William, Ghosh, Soumitra
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764033/
https://www.ncbi.nlm.nih.gov/pubmed/17206281
http://dx.doi.org/10.1371/journal.pone.0000146
_version_ 1782131581466443776
author Glisic-Milosavljevic, Sanja
Waukau, Jill
Jailwala, Parthav
Jana, Srikanta
Khoo, Huoy-Jii
Albertz, Hope
Woodliff, Jeffrey
Koppen, Marilyn
Alemzadeh, Ramin
Hagopian, William
Ghosh, Soumitra
author_facet Glisic-Milosavljevic, Sanja
Waukau, Jill
Jailwala, Parthav
Jana, Srikanta
Khoo, Huoy-Jii
Albertz, Hope
Woodliff, Jeffrey
Koppen, Marilyn
Alemzadeh, Ramin
Hagopian, William
Ghosh, Soumitra
author_sort Glisic-Milosavljevic, Sanja
collection PubMed
description BACKGROUND: In experimental models, Type 1 diabetes T1D can be prevented by adoptive transfer of CD4+CD25+ FoxP3+ suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cells to see if it could contribute to reduced suppressive activity of these cells. METHODS AND FINDINGS: T-cell apoptosis was evaluated in children and adolescent 35 females/40 males subjects comprising recent-onset and long-standing T1D subjects and their first-degree relatives, who are at variable risk to develop T1D. YOPRO1/7AAD and intracellular staining of the active form of caspase 3 were used to evaluate apoptosis. Isolated CD4+CD25+(high) and CD4+CD25− T cells were co-cultured in a suppression assay to assess the function of the former cells. We found that recent-onset T1D subjects show increased apoptosis of CD4+CD25+(high) T cells when compared to both control and long-standing T1D subjects p<0.0001 for both groups. Subjects at high risk for developing T1D 2–3Ab+ve show a similar trend p<0.02 and p<0.01, respectively. On the contrary, in long-standing T1D and T2D subjects, CD4+CD25+(high) T cell apoptosis is at the same level as in control subjects p = NS. Simultaneous intracellular staining of the active form of caspase 3 and FoxP3 confirmed recent-onset FoxP3+ve CD4+CD25+(high) T cells committed to apoptosis at a higher percentage 15.3±2.2 compared to FoxP3+ve CD4+CD25+(high) T cells in control subjects 6.1±1.7 p<0.002. Compared to control subjects, both recent-onset T1D and high at-risk subjects had significantly decreased function of CD4+CD25+(high) T cells p = 0.0007 and p = 0.007, respectively. CONCLUSIONS: There is a higher level of ongoing apoptosis in CD4+CD25+(high) T cells in recent-onset T1D subjects and in subjects at high risk for the disease. This high level of CD4+CD25+(high) T-cell apoptosis could be a contributing factor to markedly decreased suppressive potential of these cells in recent-onset T1D subjects.
format Text
id pubmed-1764033
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-17640332007-01-05 At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction Glisic-Milosavljevic, Sanja Waukau, Jill Jailwala, Parthav Jana, Srikanta Khoo, Huoy-Jii Albertz, Hope Woodliff, Jeffrey Koppen, Marilyn Alemzadeh, Ramin Hagopian, William Ghosh, Soumitra PLoS One Research Article BACKGROUND: In experimental models, Type 1 diabetes T1D can be prevented by adoptive transfer of CD4+CD25+ FoxP3+ suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cells to see if it could contribute to reduced suppressive activity of these cells. METHODS AND FINDINGS: T-cell apoptosis was evaluated in children and adolescent 35 females/40 males subjects comprising recent-onset and long-standing T1D subjects and their first-degree relatives, who are at variable risk to develop T1D. YOPRO1/7AAD and intracellular staining of the active form of caspase 3 were used to evaluate apoptosis. Isolated CD4+CD25+(high) and CD4+CD25− T cells were co-cultured in a suppression assay to assess the function of the former cells. We found that recent-onset T1D subjects show increased apoptosis of CD4+CD25+(high) T cells when compared to both control and long-standing T1D subjects p<0.0001 for both groups. Subjects at high risk for developing T1D 2–3Ab+ve show a similar trend p<0.02 and p<0.01, respectively. On the contrary, in long-standing T1D and T2D subjects, CD4+CD25+(high) T cell apoptosis is at the same level as in control subjects p = NS. Simultaneous intracellular staining of the active form of caspase 3 and FoxP3 confirmed recent-onset FoxP3+ve CD4+CD25+(high) T cells committed to apoptosis at a higher percentage 15.3±2.2 compared to FoxP3+ve CD4+CD25+(high) T cells in control subjects 6.1±1.7 p<0.002. Compared to control subjects, both recent-onset T1D and high at-risk subjects had significantly decreased function of CD4+CD25+(high) T cells p = 0.0007 and p = 0.007, respectively. CONCLUSIONS: There is a higher level of ongoing apoptosis in CD4+CD25+(high) T cells in recent-onset T1D subjects and in subjects at high risk for the disease. This high level of CD4+CD25+(high) T-cell apoptosis could be a contributing factor to markedly decreased suppressive potential of these cells in recent-onset T1D subjects. Public Library of Science 2007-01-03 /pmc/articles/PMC1764033/ /pubmed/17206281 http://dx.doi.org/10.1371/journal.pone.0000146 Text en Glisic-Milosavljevic et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Glisic-Milosavljevic, Sanja
Waukau, Jill
Jailwala, Parthav
Jana, Srikanta
Khoo, Huoy-Jii
Albertz, Hope
Woodliff, Jeffrey
Koppen, Marilyn
Alemzadeh, Ramin
Hagopian, William
Ghosh, Soumitra
At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
title At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
title_full At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
title_fullStr At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
title_full_unstemmed At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
title_short At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
title_sort at-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the cd4+cd25+(high) t-cell fraction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764033/
https://www.ncbi.nlm.nih.gov/pubmed/17206281
http://dx.doi.org/10.1371/journal.pone.0000146
work_keys_str_mv AT glisicmilosavljevicsanja atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT waukaujill atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT jailwalaparthav atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT janasrikanta atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT khoohuoyjii atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT albertzhope atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT woodliffjeffrey atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT koppenmarilyn atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT alemzadehramin atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT hagopianwilliam atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction
AT ghoshsoumitra atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction